New papers examine spliceosome termination and early lung cancer interception

Nature reports on two studies. One identifies a regulatory T-cell circuit that can be monitored in blood to track lung cancer’s development. The other uses cryo-electron microscopy to examine how RNA helicases dismantle the spliceosome—the machinery that removes segments from RNA—so its components can be recycled.